Home/Filings/4/0001209191-23-052878
4//SEC Filing

Bitetti Teresa Marie 4

Accession 0001209191-23-052878

CIK 0001805890other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:59 PM ET

Size

5.3 KB

Accession

0001209191-23-052878

Insider Transaction Report

Form 4
Period: 2023-10-16
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-16+34,00034,000 total
    Exercise: $4.16Exp: 2033-10-16Common Stock (34,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on November 16, 2023.

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1
  • filerCIK 0001977608

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:59 PM ET
Size
5.3 KB